EQUASENS (EQS.PA) Stock Fundamental Analysis

EPA:EQS • FR0012882389

34.05 EUR
-0.4 (-1.16%)
Last: Feb 24, 2026, 05:29 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

EQS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 11 industry peers in the Health Care Technology industry. While EQS has a great profitability rating, there are some minor concerns on its financial health. EQS is valued quite cheap, while showing a decent growth score. This is a good combination! EQS also has an excellent dividend rating. This makes EQS very considerable for value and dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • EQS had positive earnings in the past year.
  • EQS had a positive operating cash flow in the past year.
  • Each year in the past 5 years EQS has been profitable.
  • In the past 5 years EQS always reported a positive cash flow from operatings.
EQS.PA Yearly Net Income VS EBIT VS OCF VS FCFEQS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • EQS has a Return On Assets of 8.82%. This is in the better half of the industry: EQS outperforms 72.73% of its industry peers.
  • The Return On Equity of EQS (15.77%) is better than 90.91% of its industry peers.
  • With an excellent Return On Invested Capital value of 12.84%, EQS belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for EQS is significantly above the industry average of 8.41%.
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROIC 12.84%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
EQS.PA Yearly ROA, ROE, ROICEQS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • With an excellent Profit Margin value of 16.13%, EQS belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
  • EQS's Profit Margin has been stable in the last couple of years.
  • The Operating Margin of EQS (20.02%) is better than 81.82% of its industry peers.
  • EQS's Operating Margin has declined in the last couple of years.
  • EQS has a Gross Margin of 68.81%. This is comparable to the rest of the industry: EQS outperforms 45.45% of its industry peers.
  • In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
Industry RankSector Rank
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
EQS.PA Yearly Profit, Operating, Gross MarginsEQS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • EQS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • EQS has about the same amout of shares outstanding than it did 1 year ago.
  • EQS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, EQS has an improved debt to assets ratio.
EQS.PA Yearly Shares OutstandingEQS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EQS.PA Yearly Total Debt VS Total AssetsEQS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • EQS has an Altman-Z score of 3.56. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
  • EQS has a better Altman-Z score (3.56) than 72.73% of its industry peers.
  • EQS has a debt to FCF ratio of 0.98. This is a very positive value and a sign of high solvency as it would only need 0.98 years to pay back of all of its debts.
  • EQS has a better Debt to FCF ratio (0.98) than 72.73% of its industry peers.
  • A Debt/Equity ratio of 0.09 indicates that EQS is not too dependend on debt financing.
  • EQS has a Debt to Equity ratio of 0.09. This is in the better half of the industry: EQS outperforms 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Altman-Z 3.56
ROIC/WACC1.29
WACC9.96%
EQS.PA Yearly LT Debt VS Equity VS FCFEQS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that EQS should not have too much problems paying its short term obligations.
  • EQS has a Current ratio of 1.29. This is comparable to the rest of the industry: EQS outperforms 45.45% of its industry peers.
  • EQS has a Quick Ratio of 1.20. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
  • EQS has a Quick ratio (1.20) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.2
EQS.PA Yearly Current Assets VS Current LiabilitesEQS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for EQS have decreased strongly by -13.90% in the last year.
  • The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
  • EQS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.45%.
  • Measured over the past years, EQS shows a small growth in Revenue. The Revenue has been growing by 6.45% on average per year.
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%

3.2 Future

  • Based on estimates for the next years, EQS will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.19% on average per year.
  • The Revenue is expected to grow by 7.74% on average over the next years.
EPS Next Y11.67%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year9.26%
Revenue Next 2Y9.92%
Revenue Next 3Y9.04%
Revenue Next 5Y7.74%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EQS.PA Yearly Revenue VS EstimatesEQS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
EQS.PA Yearly EPS VS EstimatesEQS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.19 indicates a correct valuation of EQS.
  • Based on the Price/Earnings ratio, EQS is valued cheaper than 81.82% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.98. EQS is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 11.22 indicates a reasonable valuation of EQS.
  • Based on the Price/Forward Earnings ratio, EQS is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 28.01. EQS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.19
Fwd PE 11.22
EQS.PA Price Earnings VS Forward Price EarningsEQS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • EQS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EQS is cheaper than 81.82% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.85
EV/EBITDA 6.7
EQS.PA Per share dataEQS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • EQS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of EQS may justify a higher PE ratio.
  • A more expensive valuation may be justified as EQS's earnings are expected to grow with 14.19% in the coming years.
PEG (NY)1.22
PEG (5Y)2.77
EPS Next 2Y15.06%
EPS Next 3Y14.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • EQS has a Yearly Dividend Yield of 3.64%. Purely for dividend investing, there may be better candidates out there.
  • The stock price of EQS dropped by -20.72% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • EQS's Dividend Yield is a higher than the industry average which is at 2.32.
  • EQS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.64%

5.2 History

  • On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
EQS.PA Yearly Dividends per shareEQS.PA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 51.82% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
  • The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.82%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EQS.PA Yearly Income VS Free CF VS DividendEQS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EQS.PA Dividend Payout.EQS.PA Dividend Payout, showing the Payout Ratio.EQS.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EQUASENS

EPA:EQS (2/24/2026, 5:29:45 PM)

34.05

-0.4 (-1.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners11.7%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap516.54M
Revenue(TTM)224.73M
Net Income(TTM)36.26M
Analysts83.33
Price Target54.06 (58.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.64%
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.82%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 14.19
Fwd PE 11.22
P/S 2.3
P/FCF 13.85
P/OCF 10.59
P/B 2.25
P/tB 6.47
EV/EBITDA 6.7
EPS(TTM)2.4
EY7.05%
EPS(NY)3.04
Fwd EY8.91%
FCF(TTM)2.46
FCFY7.22%
OCF(TTM)3.22
OCFY9.44%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.22
PEG (5Y)2.77
Graham Number28.61
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROCE 15.76%
ROIC 12.84%
ROICexc 18.12%
ROICexgc 70.2%
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
FCFM 16.6%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.08%
ROICexc(5y)21.2%
ROICexgc(3y)48.92%
ROICexgc(5y)61.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-28.73%
ROICexgc growth 5Y-12.2%
ROICexc growth 3Y-17.5%
ROICexc growth 5Y-11.29%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Debt/EBITDA 0.32
Cap/Depr 70.06%
Cap/Sales 5.11%
Interest Coverage 250
Cash Conversion 79.48%
Profit Quality 102.89%
Current Ratio 1.29
Quick Ratio 1.2
Altman-Z 3.56
F-Score7
WACC9.96%
ROIC/WACC1.29
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y11.67%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.26%
Revenue Next 2Y9.92%
Revenue Next 3Y9.04%
Revenue Next 5Y7.74%
EBIT growth 1Y-7%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year55.72%
EBIT Next 3Y25.38%
EBIT Next 5YN/A
FCF growth 1Y-36.45%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-30.97%
OCF growth 3Y0.02%
OCF growth 5Y3.18%

EQUASENS / EQS.PA FAQ

What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.


What is the valuation status of EQUASENS (EQS.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to EQUASENS (EQS.PA). This can be considered as Undervalued.


What is the profitability of EQS stock?

EQUASENS (EQS.PA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for EQS stock?

The Price/Earnings (PE) ratio for EQUASENS (EQS.PA) is 14.19 and the Price/Book (PB) ratio is 2.25.


What is the expected EPS growth for EQUASENS (EQS.PA) stock?

The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 11.67% in the next year.